HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

Brevan Howard Capital Management LP's Holding History (CIK: 0001512857)

Note: Option positions (PUT/CALL) are excluded.

Q3 2025

Shares 64,217 Value ($000) $4,710 Avg Close $66.43 Range $51.78 - $79.50

Q2 2025

Shares 161,023 Value ($000) $8,376 Avg Close $56.90 Range $47.50 - $70.51

Q1 2025

Shares 15,216 Value ($000) $971 Avg Close $58.09 Range $47.52 - $66.00

Q4 2024

Shares 20,996 Value ($000) $1,004 Avg Close $51.28 Range $42.01 - $62.13

Q2 2024

Shares 19,808 Value ($000) $1,037 Avg Close $43.86 Range $37.73 - $53.00

Q4 2023

Shares 9,294 Value ($000) $344 Avg Close $37.66 Range $32.83 - $42.82

Period	Shares	Value ($000)	Average Close	Price Range
Q3 2025	64,217	$4,710	$66.43	$51.78 - $79.50
Q2 2025	161,023	$8,376	$56.90	$47.50 - $70.51
Q1 2025	15,216	$971	$58.09	$47.52 - $66.00
Q4 2024	20,996	$1,004	$51.28	$42.01 - $62.13
Q2 2024	19,808	$1,037	$43.86	$37.73 - $53.00
Q4 2023	9,294	$344	$37.66	$32.83 - $42.82